• IMS Health Bulgaria

Driving Healthcare Performance in Bulgaria

IMS Health commenced its Bulgarian operations in 1993, with a retail pharmaceutical market audit. Offerings covering the hospital market, regional reports, and promotional effort measuring followed by consulting services were added in 2008. At IMS Health Bulgaria, our information, analytics, and therapy expertise, together with other primary market research projects, enable our clients to optimize their commercial effectiveness, while our constantly expanding capabilities in management consulting deliver immediate and significant gains for their businesses.

We have tracked the changes and developments in the Bulgarian pharmaceutical market for almost two decades and in 2012 the total pharmaceutical market in Bulgaria reached €1.13bn, representing a 5.2% increase from the previous year. The key therapy area is still Cardiovascular contributing close to 22% of the total market, with oncology the fastest growing showing a year-on-year growth of over 26% for 2012.

There are 183 corporations operating in the Bulgarian pharmaceutical market, the top ten accounting for over half of total sales and only one of these ten being a local Bulgarian company.